Epigenomics Market By Product (Reagents, Kits (Whole Genomic Amplification kit, RNA Sequencing Kit, Chip sequencing kit, Bisulfite Conversion kit, Others), Enzymes, Instruments and Services) By Application (Oncology and Non oncology) By Technology (DNA Methylation, MicroRNA Modification, Large non-coding RNA, Histone Methylation and Histone Acetylation), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: Aug 2025
- Report ID: 155594
- Number of Pages: 354
- Format:
-
-
- 1. Executive Summary
- 1.1. Definition
- 1.2. Market Snapshot
- 1.3. Market Overview
- 1.4. Segment Overview
- 1.5. Regional Overview
- 1.6. Competitive Landscape
- 1.7. Taxonomy
- 1.8. Industry Voices
- 2. Global Market Overview
- 2.1. Global Market Insights and Industry Overview
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunities
- 2.2.4. Key Epigenomics Market Trends
- 2.3. Technology Landscape
- 2.4. Regulatory Framework
- 2.5. Sustainability and ESG (Environmental, Social, Governance)
- 2.6. Opportunity Map Analysis
- 2.7. Opportunity Orbits
- 2.8. PESTLE Analysis
- 2.9. PORTER’S Five Force Analysis
- 2.10. Drivers & Restraints Impact Analysis
- 2.11. Value Chain Analysis
- 2.11.1. List of Raw Materials Suppliers
- 2.11.2. List of Epigenomics Manufacturers
- 2.11.3. List of Dealer/Distributors
- 2.12. Regional Market Share and BPS Analysis
- 2.13. Impact of Macro-economic Factors/Geopolitical Factors
- 3. Global Epigenomics Market Analysis and Forecast, By Segment, 2020-2034
- 3.1. Key Findings
- 3.2. Global Epigenomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2020-2034
- 3.3. Global Epigenomics Market Attractiveness Analysis, By Product
- 3.3.1. Reagents
- 3.3.1.1. Insights
- 3.3.1.2. Key Takeaways
- 3.3.2. Kits
- 3.3.2.1. Insights
- 3.3.2.2. Key Takeaways
- 3.3.2.2.1. Whole Genomic Amplification kit
- 3.3.2.2.2. RNA Sequencing Kit
- 3.3.2.2.3. Chip sequencing kit
- 3.3.2.2.4. Bisulfite Conversion kit
- 3.3.2.2.5. Others
- 3.3.3. Enzymes
- 3.3.3.1. Insights
- 3.3.3.2. Key Takeaways
- 3.3.4. Instruments
- 3.3.4.1. Insights
- 3.3.4.2. Key Takeaways
- 3.3.5. Services
- 3.3.5.1. Insights
- 3.3.5.2. Key Takeaways
- 3.3.1. Reagents
- 3.4. Global Epigenomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
- 3.5. Global Epigenomics Market Attractiveness Analysis, By Application
- 3.5.1. Oncology
- 3.5.1.1. Insights
- 3.5.1.2. Key Takeaways
- 3.5.2. Non-Oncology
- 3.5.2.1. Insights
- 3.5.2.2. Key Takeaways
- 3.5.1. Oncology
- 3.6. Global Epigenomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
- 3.7. Global Epigenomics Market Attractiveness Analysis, By Technology
- 3.7.1. DNA Methylation
- 3.7.1.1. Insights
- 3.7.1.2. Key Takeaways
- 3.7.2. MicroRNA Modification
- 3.7.2.1. Insights
- 3.7.2.2. Key Takeaways
- 3.7.3. Large Non-Coding RNA
- 3.7.3.1. Insights
- 3.7.3.2. Key Takeaways
- 3.7.4. Histone Methylation
- 3.7.4.1. Insights
- 3.7.4.2. Key Takeaways
- 3.7.5. Histone Acetylation
- 3.7.5.1. Insights
- 3.7.5.2. Key Takeaways
- 3.7.1. DNA Methylation
- 4. Global Epigenomics Market Analysis and Forecast, By Region, 2020-2034
- 4.1. Key Findings
- 4.2. Global Epigenomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
- 4.2.1. North America
- 4.2.1.1. Regional Insights
- 4.2.2. Europe
- 4.2.2.1. Regional Insights
- 4.2.3. Asia Pacific
- 4.2.3.1. Regional Insights
- 4.2.4. Latin America
- 4.2.4.1. Regional Insights
- 4.2.5. Middle East & Africa
- 4.2.5.1. Regional Insights
- 4.2.1. North America
- 4.3. Global Epigenomics Market Attractiveness Analysis, By Region
- 5. North America Epigenomics Market Analysis and Forecast, 2020-2034
- 5.1. Key Findings
- 5.2. North America Epigenomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2020-2034
- 5.3. North America Epigenomics Market Attractiveness Analysis, By Product
- 5.4. North America Epigenomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
- 5.5. North America Epigenomics Market Attractiveness Analysis, By Application
- 5.6. North America Epigenomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
- 5.7. North America Epigenomics Market Attractiveness Analysis, By Technology
- 5.8. North America Epigenomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
- 5.9. North America Epigenomics Market Attractiveness Analysis, By Country
- 5.9.1. The US
- 5.9.2. Canada
- 6. Europe Epigenomics Market Analysis and Forecast, 2020-2034
- 6.1. Key Findings
- 6.2. Europe Epigenomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2020-2034
- 6.3. Europe Epigenomics Market Attractiveness Analysis, By Product
- 6.4. Europe Epigenomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
- 6.5. Europe Epigenomics Market Attractiveness Analysis, By Application
- 6.6. Europe Epigenomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
- 6.7. Europe Epigenomics Market Attractiveness Analysis, By Technology
- 6.8. Europe Epigenomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
- 6.9. Europe Epigenomics Market Attractiveness Analysis, By Country
- 6.9.1. Germany
- 6.9.2. The UK
- 6.9.3. France
- 6.9.4. Spain
- 6.9.5. Italy
- 6.9.6. Russia
- 6.9.7. Netherland
- 6.9.8. Rest of Europe
- 7. Asia Pacific Epigenomics Market Analysis and Forecast, 2020-2034
- 7.1. Key Findings
- 7.2. Asia Pacific Epigenomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2020-2034
- 7.3. Asia Pacific Epigenomics Market Attractiveness Analysis, By Product
- 7.4. Asia Pacific Epigenomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
- 7.5. Asia Pacific Epigenomics Market Attractiveness Analysis, By Application
- 7.6. Asia Pacific Epigenomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
- 7.7. Asia Pacific Epigenomics Market Attractiveness Analysis, By Technology
- 7.8. Asia Pacific Epigenomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
- 7.9. Asia Pacific Epigenomics Market Attractiveness Analysis, By Country
- 7.9.1. China
- 7.9.2. Japan
- 7.9.3. South Korea
- 7.9.4. India
- 7.9.5. Australia
- 7.9.6. New Zealand
- 7.9.7. Singapore
- 7.9.8. Thailand
- 7.9.9. Vietnam
- 7.9.10. Rest of Asia Pacific
- 8. Latin America Epigenomics Market Analysis and Forecast, 2020-2034
- 8.1. Key Findings
- 8.2. Latin America Epigenomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2020-2034
- 8.3. Latin America Epigenomics Market Attractiveness Analysis, By Product
- 8.4. Latin America Epigenomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
- 8.5. Latin America Epigenomics Market Attractiveness Analysis, By Application
- 8.6. Latin America Epigenomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
- 8.7. Latin America Epigenomics Market Attractiveness Analysis, By Technology
- 8.8. Latin America Epigenomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
- 8.9. Latin America Epigenomics Market Attractiveness Analysis, By Country
- 8.9.1. Brazil
- 8.9.2. Mexico
- 8.9.3. Rest of Latin America
- 9. Middle East & Africa Epigenomics Market Analysis and Forecast, 2020-2034
- 9.1. Key Findings
- 9.2. Middle East & Africa Epigenomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2020-2034
- 9.3. Middle East & Africa Epigenomics Market Attractiveness Analysis, By Product
- 9.4. Middle East & Africa Epigenomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
- 9.5. Middle East & Africa Epigenomics Market Attractiveness Analysis, By Application
- 9.6. Middle East & Africa Epigenomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2020-2034
- 9.7. Middle East & Africa Epigenomics Market Attractiveness Analysis, By Technology
- 9.8. Middle East & Africa Epigenomics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
- 9.9. Middle East & Africa Epigenomics Market Attractiveness Analysis, By Country
- 9.9.1. South Africa
- 9.9.2. Saudi Arabia
- 9.9.3. UAE
- 9.9.4. Rest of Middle East & Africa
- 10. Competitive Landscape & Company Profiles
- 10.1. Market Competition Scenario Analysis, By Company
- 10.1.1. Key Takeaways
- 10.2. Overview of Major Market Players
- 10.3. Competitor Landscape
- 10.4. Strategic Mapping
- 10.5. Company Life Cycle Analysis
- 10.6. Company Market Share Analysis
- 10.7. Company Profiles
- 10.7.1. Zymo Research
- 10.7.1.1. Company Details
- 10.7.1.2. Business Overview
- 10.7.1.3. Product Portfolio
- 10.7.1.4. Financial Insights
- 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.1.6. SWOT Analysis
- 10.7.1.7. Geographic Footprint
- 10.7.2. Thermo Fisher Scientific
- 10.7.2.1. Company Details
- 10.7.2.2. Business Overview
- 10.7.2.3. Product Portfolio
- 10.7.2.4. Financial Insights
- 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.2.6. SWOT Analysis
- 10.7.2.7. Geographic Footprint
- 10.7.3. QIAGEN
- 10.7.3.1. Company Details
- 10.7.3.2. Business Overview
- 10.7.3.3. Product Portfolio
- 10.7.3.4. Financial Insights
- 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.3.6. SWOT Analysis
- 10.7.3.7. Geographic Footprint
- 10.7.4. PerkinElmer
- 10.7.4.1. Company Details
- 10.7.4.2. Business Overview
- 10.7.4.3. Product Portfolio
- 10.7.4.4. Financial Insights
- 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.4.6. SWOT Analysis
- 10.7.4.7. Geographic Footprint
- 10.7.5. Pacific Biosciences
- 10.7.5.1. Company Details
- 10.7.5.2. Business Overview
- 10.7.5.3. Product Portfolio
- 10.7.5.4. Financial Insights
- 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.5.6. SWOT Analysis
- 10.7.5.7. Geographic Footprint
- 10.7.6. New England Biolabs
- 10.7.6.1. Company Details
- 10.7.6.2. Business Overview
- 10.7.6.3. Product Portfolio
- 10.7.6.4. Financial Insights
- 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.6.6. SWOT Analysis
- 10.7.6.7. Geographic Footprint
- 10.7.7. Merck KGaA
- 10.7.7.1. Company Details
- 10.7.7.2. Business Overview
- 10.7.7.3. Product Portfolio
- 10.7.7.4. Financial Insights
- 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.7.6. SWOT Analysis
- 10.7.7.7. Geographic Footprint
- 10.7.8. Illumina
- 10.7.8.1. Company Details
- 10.7.8.2. Business Overview
- 10.7.8.3. Product Portfolio
- 10.7.8.4. Financial Insights
- 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.8.6. SWOT Analysis
- 10.7.8.7. Geographic Footprint
- 10.7.9. Bio-Rad Laboratories
- 10.7.9.1. Company Details
- 10.7.9.2. Business Overview
- 10.7.9.3. Product Portfolio
- 10.7.9.4. Financial Insights
- 10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.9.6. SWOT Analysis
- 10.7.9.7. Geographic Footprint
- 10.7.10. Agilent Technologies
- 10.7.10.1. Company Details
- 10.7.10.2. Business Overview
- 10.7.10.3. Product Portfolio
- 10.7.10.4. Financial Insights
- 10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.10.6. SWOT Analysis
- 10.7.10.7. Geographic Footprint
- 10.7.11. Active Motif
- 10.7.11.1. Company Details
- 10.7.11.2. Business Overview
- 10.7.11.3. Product Portfolio
- 10.7.11.4. Financial Insights
- 10.7.11.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.11.6. SWOT Analysis
- 10.7.11.7. Geographic Footprint
- 10.7.12. Abcam
- 10.7.12.1. Company Details
- 10.7.12.2. Business Overview
- 10.7.12.3. Product Portfolio
- 10.7.12.4. Financial Insights
- 10.7.12.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.12.6. SWOT Analysis
- 10.7.12.7. Geographic Footprint
- 10.7.1. Zymo Research
- 10.1. Market Competition Scenario Analysis, By Company
- 11. Methodology and Data Source
- 11.1. Methodology/Research Approach
- 11.2. Market Size Estimation
- 11.3. Market Breakdown and Data Triangulation
- 11.4. Data Source
- 11.5. Secondary Sources
- 11.6. Primary Sources
- 11.7. Appendix
- 11.8. Disclaimer
- List of Tables
- Table 1. Global Epigenomics Market Value (US$ Mn), By Product, 2020–2034
- Table 2. Global Epigenomics Market Value (US$ Mn), By Kits, 2020–2034
- Table 3. Global Epigenomics Market Value (US$ Mn), By Application, 2020–2034
- Table 4. Global Epigenomics Market Value (US$ Mn), By Technology, 2020–2034
- Table 5. Global Epigenomics Market Value (US$ Mn), By Region, 2020-2034
- Table 6. North America Epigenomics Market Value (US$ Mn), By Product, 2020–2034
- Table 7. North America Epigenomics Market Value (US$ Mn), By Kits, 2020–2034
- Table 8. North America Epigenomics Market Value (US$ Mn), By Application, 2020–2034
- Table 9. North America Epigenomics Market Value (US$ Mn), By Technology, 2020–2034
- Table 10. North America Epigenomics Market Value (US$ Mn), By Country, 2020–2034
- Table 11. The US Epigenomics Market Value (US$ Mn), By Product, 2020–2034
- Table 12. The US Epigenomics Market Value (US$ Mn), By Kits, 2020–2034
- Table 13. The US Epigenomics Market Value (US$ Mn), By Application, 2020–2034
- Table 14. The US Epigenomics Market Value (US$ Mn), By Technology, 2020–2034
- Table 15. Canada Epigenomics Market Value (US$ Mn), By Product, 2020–2034
- Table 16. Canada Epigenomics Market Value (US$ Mn), By Kits, 2020–2034
- Table 17. Canada Epigenomics Market Value (US$ Mn), By Application, 2020–2034
- Table 18. Canada Epigenomics Market Value (US$ Mn), By Technology, 2020–2034
- Table 19. Europe Epigenomics Market Value (US$ Mn), By Product, 2020–2034
- Table 20. Europe Epigenomics Market Value (US$ Mn), By Kits, 2020–2034
- Table 21. Europe Epigenomics Market Value (US$ Mn), By Application, 2020–2034
- Table 22. Europe Epigenomics Market Value (US$ Mn), By Technology, 2020–2034
- Table 23. Europe Epigenomics Market Value (US$ Mn), By Country, 2020–2034
- Table 24. Germany Epigenomics Market Value (US$ Mn), By Product, 2020–2034
- Table 25. Germany Epigenomics Market Value (US$ Mn), By Kits, 2020–2034
- Table 26. Germany Epigenomics Market Value (US$ Mn), By Application, 2020–2034
- Table 27. Germany Epigenomics Market Value (US$ Mn), By Technology, 2020–2034
- Table 28. France Epigenomics Market Value (US$ Mn), By Product, 2020–2034
- Table 29. France Epigenomics Market Value (US$ Mn), By Kits, 2020–2034
- Table 30. France Epigenomics Market Value (US$ Mn), By Application, 2020–2034
- Table 31. France Epigenomics Market Value (US$ Mn), By Technology, 2020–2034
- Table 32. UK Epigenomics Market Value (US$ Mn), By Product, 2020–2034
- Table 33. UK Epigenomics Market Value (US$ Mn), By Kits, 2020–2034
- Table 34. UK Epigenomics Market Value (US$ Mn), By Application, 2020–2034
- Table 35. UK Epigenomics Market Value (US$ Mn), By Technology, 2020–2034
- Table 36. Spain Epigenomics Market Value (US$ Mn), By Product, 2020–2034
- Table 37. Spain Epigenomics Market Value (US$ Mn), By Kits, 2020–2034
- Table 38. Spain Epigenomics Market Value (US$ Mn), By Application, 2020–2034
- Table 39. Spain Epigenomics Market Value (US$ Mn), By Technology, 2020–2034
- Table 40. Italy Epigenomics Market Value (US$ Mn), By Product, 2020–2034
- Table 41. Italy Epigenomics Market Value (US$ Mn), By Kits, 2020–2034
- Table 42. Italy Epigenomics Market Value (US$ Mn), By Application, 2020–2034
- Table 43. Italy Epigenomics Market Value (US$ Mn), By Technology, 2020–2034
- Table 44. Russia Epigenomics Market Value (US$ Mn), By Product, 2020–2034
- Table 45. Russia Epigenomics Market Value (US$ Mn), By Kits, 2020–2034
- Table 46. Russia Epigenomics Market Value (US$ Mn), By Application, 2020–2034
- Table 47. Russia Epigenomics Market Value (US$ Mn), By Technology, 2020–2034
- Table 48. Netherlands Epigenomics Market Value (US$ Mn), By Product, 2020–2034
- Table 49. Netherlands Epigenomics Market Value (US$ Mn), By Kits, 2020–2034
- Table 50. Netherlands Epigenomics Market Value (US$ Mn), By Application, 2020–2034
- Table 51. Netherlands Epigenomics Market Value (US$ Mn), By Technology, 2020–2034
- Table 52. Rest of Europe Epigenomics Market Value (US$ Mn), By Product, 2020–2034
- Table 53. Rest of Europe Epigenomics Market Value (US$ Mn), By Kits, 2020–2034
- Table 54. Rest of Europe Epigenomics Market Value (US$ Mn), By Application, 2020–2034
- Table 55. Rest of Europe Epigenomics Market Value (US$ Mn), By Technology, 2020–2034
- Table 56. Asia Pacific Epigenomics Market Value (US$ Mn), By Product, 2020–2034
- Table 57. Asia Pacific Epigenomics Market Value (US$ Mn), By Kits, 2020–2034
- Table 58. Asia Pacific Epigenomics Market Value (US$ Mn), By Application, 2020–2034
- Table 59. Asia Pacific Epigenomics Market Value (US$ Mn), By Technology, 2020–2034
- Table 60. Asia Pacific Epigenomics Market Value (US$ Mn), By Country, 2020–2034
- Table 61. China Epigenomics Market Value (US$ Mn), By Product, 2020–2034
- Table 62. China Epigenomics Market Value (US$ Mn), By Kits, 2020–2034
- Table 63. China Epigenomics Market Value (US$ Mn), By Application, 2020–2034
- Table 64. China Epigenomics Market Value (US$ Mn), By Technology, 2020–2034
- Table 65. Japan Epigenomics Market Value (US$ Mn), By Product, 2020–2034
- Table 66. Japan Epigenomics Market Value (US$ Mn), By Kits, 2020–2034
- Table 67. Japan Epigenomics Market Value (US$ Mn), By Application, 2020–2034
- Table 68. Japan Epigenomics Market Value (US$ Mn), By Technology, 2020–2034
- Table 69. South Korea Epigenomics Market Value (US$ Mn), By Product, 2020–2034
- Table 70. South Korea Epigenomics Market Value (US$ Mn), By Kits, 2020–2034
- Table 71. South Korea Epigenomics Market Value (US$ Mn), By Application, 2020–2034
- Table 72. South Korea Epigenomics Market Value (US$ Mn), By Technology, 2020–2034
- Table 73. India Epigenomics Market Value (US$ Mn), By Product, 2020–2034
- Table 74. India Epigenomics Market Value (US$ Mn), By Kits, 2020–2034
- Table 75. India Epigenomics Market Value (US$ Mn), By Application, 2020–2034
- Table 76. India Epigenomics Market Value (US$ Mn), By Technology, 2020–2034
- Table 77. Australia Epigenomics Market Value (US$ Mn), By Product, 2020–2034
- Table 78. Australia Epigenomics Market Value (US$ Mn), By Kits, 2020–2034
- Table 79. Australia Epigenomics Market Value (US$ Mn), By Application, 2020–2034
- Table 80. Australia Epigenomics Market Value (US$ Mn), By Technology, 2020–2034
- Table 81. New Zealand Epigenomics Market Value (US$ Mn), By Product, 2020–2034
- Table 82. New Zealand Epigenomics Market Value (US$ Mn), By Kits, 2020–2034
- Table 83. New Zealand Epigenomics Market Value (US$ Mn), By Application, 2020–2034
- Table 84. New Zealand Epigenomics Market Value (US$ Mn), By Technology, 2020–2034
- Table 85. Singapore Epigenomics Market Value (US$ Mn), By Product, 2020–2034
- Table 86. Singapore Epigenomics Market Value (US$ Mn), By Kits, 2020–2034
- Table 87. Singapore Epigenomics Market Value (US$ Mn), By Application, 2020–2034
- Table 88. Singapore Epigenomics Market Value (US$ Mn), By Technology, 2020–2034
- Table 89. Thailand Epigenomics Market Value (US$ Mn), By Product, 2020–2034
- Table 90. Thailand Epigenomics Market Value (US$ Mn), By Kits, 2020–2034
- Table 91. Thailand Epigenomics Market Value (US$ Mn), By Application, 2020–2034
- Table 92. Thailand Epigenomics Market Value (US$ Mn), By Technology, 2020–2034
- Table 93. Vietnam Epigenomics Market Value (US$ Mn), By Product, 2020–2034
- Table 94. Vietnam Epigenomics Market Value (US$ Mn), By Kits, 2020–2034
- Table 95. Vietnam Epigenomics Market Value (US$ Mn), By Application, 2020–2034
- Table 96. Vietnam Epigenomics Market Value (US$ Mn), By Technology, 2020–2034
- Table 97. Rest of Asia Pacific Epigenomics Market Value (US$ Mn), By Product, 2020–2034
- Table 98. Rest of Asia Pacific Epigenomics Market Value (US$ Mn), By Kits, 2020–2034
- Table 99. Rest of Asia Pacific Epigenomics Market Value (US$ Mn), By Application, 2020–2034
- Table 100. Rest of Asia Pacific Epigenomics Market Value (US$ Mn), By Technology, 2020–2034
- Table 101. Latin America Epigenomics Market Value (US$ Mn), By Product, 2020–2034
- Table 102. Latin America Epigenomics Market Value (US$ Mn), By Kits, 2020–2034
- Table 103. Latin America Epigenomics Market Value (US$ Mn), By Application, 2020–2034
- Table 104. Latin America Epigenomics Market Value (US$ Mn), By Technology, 2020–2034
- Table 105. Latin America Epigenomics Market Value (US$ Mn), By Country, 2020–2034
- Table 106. Brazil Epigenomics Market Value (US$ Mn), By Product, 2020–2034
- Table 107. Brazil Epigenomics Market Value (US$ Mn), By Kits, 2020–2034
- Table 108. Brazil Epigenomics Market Value (US$ Mn), By Application, 2020–2034
- Table 109. Brazil Epigenomics Market Value (US$ Mn), By Technology, 2020–2034
- Table 110. Mexico Epigenomics Market Value (US$ Mn), By Product, 2020–2034
- Table 111. Mexico Epigenomics Market Value (US$ Mn), By Kits, 2020–2034
- Table 112. Mexico Epigenomics Market Value (US$ Mn), By Application, 2020–2034
- Table 113. Mexico Epigenomics Market Value (US$ Mn), By Technology, 2020–2034
- Table 114. Rest of Latin America Epigenomics Market Value (US$ Mn), By Product, 2020–2034
- Table 115. Rest of Latin America Epigenomics Market Value (US$ Mn), By Kits, 2020–2034
- Table 116. Rest of Latin America Epigenomics Market Value (US$ Mn), By Application, 2020–2034
- Table 117. Rest of Latin America Epigenomics Market Value (US$ Mn), By Technology, 2020–2034
- Table 118. Middle East & Africa Epigenomics Market Value (US$ Mn), By Product, 2020–2034
- Table 119. Middle East & Africa Epigenomics Market Value (US$ Mn), By Kits, 2020–2034
- Table 120. Middle East & Africa Epigenomics Market Value (US$ Mn), By Application, 2020–2034
- Table 121. Middle East & Africa Epigenomics Market Value (US$ Mn), By Technology, 2020–2034
- Table 122. Middle East & Africa Epigenomics Market Value (US$ Mn), By Country, 2020–2034
- Table 123. South Africa Epigenomics Market Value (US$ Mn), By Product, 2020–2034
- Table 124. South Africa Epigenomics Market Value (US$ Mn), By Kits, 2020–2034
- Table 125. South Africa Epigenomics Market Value (US$ Mn), By Application, 2020–2034
- Table 126. South Africa Epigenomics Market Value (US$ Mn), By Technology, 2020–2034
- Table 127. Saudi Arabia Epigenomics Market Value (US$ Mn), By Product, 2020–2034
- Table 128. Saudi Arabia Epigenomics Market Value (US$ Mn), By Kits, 2020–2034
- Table 129. Saudi Arabia Epigenomics Market Value (US$ Mn), By Application, 2020–2034
- Table 130. Saudi Arabia Epigenomics Market Value (US$ Mn), By Technology, 2020–2034
- Table 131. UAE Epigenomics Market Value (US$ Mn), By Product, 2020–2034
- Table 132. UAE Epigenomics Market Value (US$ Mn), By Kits, 2020–2034
- Table 133. UAE Epigenomics Market Value (US$ Mn), By Application, 2020–2034
- Table 134. UAE Epigenomics Market Value (US$ Mn), By Technology, 2020–2034
- Table 135. Rest of Middle East & Africa Epigenomics Market Value (US$ Mn), By Product, 2020–2034
- Table 136. Rest of Middle East & Africa Epigenomics Market Value (US$ Mn), By Kits, 2020–2034
- Table 137. Rest of Middle East & Africa Epigenomics Market Value (US$ Mn), By Application, 2020–2034
- Table 138. Rest of Middle East & Africa Epigenomics Market Value (US$ Mn), By Technology, 2020–2034
- List of Figures
- Figure 1. Global Epigenomics Market Snapshot: Market Value (US$ Mn), 2020-2034
- Figure 2. Opportunity Map
- Figure 3. Opportunity Orbit
- Figure 4. Regional Market Share and BPS Analysis in Epigenomics Market
- Figure 5. Global Epigenomics Market Analysis, By Product, 2020, 2024 and 2034
- Figure 6. Global Epigenomics Market Attractiveness Analysis, By Product
- Figure 7. Global Epigenomics Market Analysis, By Application, 2020, 2024 and 2034
- Figure 8. Global Epigenomics Market Attractiveness Analysis, By Application
- Figure 9. Global Epigenomics Market Analysis, By Technology, 2020, 2024 and 2034
- Figure 10. Global Epigenomics Market Attractiveness Analysis, By Technology
- Figure 11. Global Epigenomics Market Analysis, By Region, 2020, 2024 and 2034
- Figure 12. Global Epigenomics Market Attractiveness Analysis, By Region
- Figure 13. North America Epigenomics Market Analysis, By Product, 2020, 2024 and 2034
- Figure 14. North America Epigenomics Market Attractiveness Analysis, By Product
- Figure 15. North America Epigenomics Market (US$ Mn), by Reagents, 2020-2034
- Figure 16. North America Epigenomics Market (US$ Mn), by Kits, 2020-2034
- Figure 17. North America Epigenomics Market (US$ Mn), by Enzymes, 2020-2034
- Figure 18. North America Epigenomics Market (US$ Mn), by Instruments, 2020-2034
- Figure 19. North America Epigenomics Market (US$ Mn), by Services, 2020-2034
- Figure 20. North America Epigenomics Market Analysis, By Application, 2020, 2024 and 2034
- Figure 21. North America Epigenomics Market Attractiveness Analysis, By Application
- Figure 22. North America Epigenomics Market (US$ Mn), by Oncology, 2020-2034
- Figure 23. North America Epigenomics Market (US$ Mn), by Non-Oncology, 2020-2034
- Figure 24. North America Epigenomics Market Analysis, By Technology, 2020, 2024 and 2034
- Figure 25. North America Epigenomics Market Attractiveness Analysis, By Technology
- Figure 26. North America Epigenomics Market (US$ Mn), by DNA Methylation, 2020-2034
- Figure 27. North America Epigenomics Market (US$ Mn), by MicroRNA Modification, 2020-2034
- Figure 28. North America Epigenomics Market (US$ Mn), by Large Non-Coding RNA, 2020-2034
- Figure 29. North America Epigenomics Market (US$ Mn), by Histone Methylation, 2020-2034
- Figure 30. North America Epigenomics Market (US$ Mn), by Histone Acetylation, 2020-2034
- Figure 31. North America Epigenomics Market Analysis, By Country, 2020, 2024 and 2034
- Figure 32. North America Epigenomics Market Attractiveness Analysis, By Country
- Figure 33. Europe Epigenomics Market Analysis, By Product, 2020, 2024 and 2034
- Figure 34. Europe Epigenomics Market Attractiveness Analysis, By Product
- Figure 35. Europe Epigenomics Market (US$ Mn), by Reagents, 2020-2034
- Figure 36. Europe Epigenomics Market (US$ Mn), by Kits, 2020-2034
- Figure 37. Europe Epigenomics Market (US$ Mn), by Enzymes, 2020-2034
- Figure 38. Europe Epigenomics Market (US$ Mn), by Instruments, 2020-2034
- Figure 39. Europe Epigenomics Market (US$ Mn), by Services, 2020-2034
- Figure 40. Europe Epigenomics Market Analysis, By Application, 2020, 2024 and 2034
- Figure 41. Europe Epigenomics Market Attractiveness Analysis, By Application
- Figure 42. Europe Epigenomics Market (US$ Mn), by Oncology, 2020-2034
- Figure 43. Europe Epigenomics Market (US$ Mn), by Non-Oncology, 2020-2034
- Figure 44. Europe Epigenomics Market Analysis, By Technology, 2020, 2024 and 2034
- Figure 45. Europe Epigenomics Market Attractiveness Analysis, By Technology
- Figure 46. Europe Epigenomics Market (US$ Mn), by DNA Methylation, 2020-2034
- Figure 47. Europe Epigenomics Market (US$ Mn), by MicroRNA Modification, 2020-2034
- Figure 48. Europe Epigenomics Market (US$ Mn), by Large Non-Coding RNA, 2020-2034
- Figure 49. Europe Epigenomics Market (US$ Mn), by Histone Methylation, 2020-2034
- Figure 50. Europe Epigenomics Market (US$ Mn), by Histone Acetylation, 2020-2034
- Figure 51. Europe Epigenomics Market Analysis, By Country, 2020, 2024 and 2034
- Figure 52. Europe Epigenomics Market Attractiveness Analysis, By Country
- Figure 53. Asia Pacific Epigenomics Market Analysis, By Product, 2020, 2024 and 2034
- Figure 54. Asia Pacific Epigenomics Market Attractiveness Analysis, By Product
- Figure 55. Asia Pacific Epigenomics Market (US$ Mn), by Reagents, 2020-2034
- Figure 56. Asia Pacific Epigenomics Market (US$ Mn), by Kits, 2020-2034
- Figure 57. Asia Pacific Epigenomics Market (US$ Mn), by Enzymes, 2020-2034
- Figure 58. Asia Pacific Epigenomics Market (US$ Mn), by Instruments, 2020-2034
- Figure 59. Asia Pacific Epigenomics Market (US$ Mn), by Services, 2020-2034
- Figure 60. Asia Pacific Epigenomics Market Analysis, By Application, 2020, 2024 and 2034
- Figure 61. Asia Pacific Epigenomics Market Attractiveness Analysis, By Application
- Figure 62. Asia Pacific Epigenomics Market (US$ Mn), by Oncology, 2020-2034
- Figure 63. Asia Pacific Epigenomics Market (US$ Mn), by Non-Oncology, 2020-2034
- Figure 64. Asia Pacific Epigenomics Market Analysis, By Technology, 2020, 2024 and 2034
- Figure 65. Asia Pacific Epigenomics Market Attractiveness Analysis, By Technology
- Figure 66. Asia Pacific Epigenomics Market (US$ Mn), by DNA Methylation, 2020-2034
- Figure 67. Asia Pacific Epigenomics Market (US$ Mn), by MicroRNA Modification, 2020-2034
- Figure 68. Asia Pacific Epigenomics Market (US$ Mn), by Large Non-Coding RNA, 2020-2034
- Figure 69. Asia Pacific Epigenomics Market (US$ Mn), by Histone Methylation, 2020-2034
- Figure 70. Asia Pacific Epigenomics Market (US$ Mn), by Histone Acetylation, 2020-2034
- Figure 71. Asia Pacific Epigenomics Market Analysis, By Country, 2020, 2024 and 2034
- Figure 72. Asia Pacific Epigenomics Market Attractiveness Analysis, By Country
- Figure 73. Latin America Epigenomics Market Analysis, By Product, 2020, 2024 and 2034
- Figure 74. Latin America Epigenomics Market Attractiveness Analysis, By Product
- Figure 75. Latin America Epigenomics Market (US$ Mn), by Reagents, 2020-2034
- Figure 76. Latin America Epigenomics Market (US$ Mn), by Kits, 2020-2034
- Figure 77. Latin America Epigenomics Market (US$ Mn), by Enzymes, 2020-2034
- Figure 78. Latin America Epigenomics Market (US$ Mn), by Instruments, 2020-2034
- Figure 79. Latin America Epigenomics Market (US$ Mn), by Services, 2020-2034
- Figure 80. Latin America Epigenomics Market Analysis, By Application, 2020, 2024 and 2034
- Figure 81. Latin America Epigenomics Market Attractiveness Analysis, By Application
- Figure 82. Latin America Epigenomics Market (US$ Mn), by Oncology, 2020-2034
- Figure 83. Latin America Epigenomics Market (US$ Mn), by Non-Oncology, 2020-2034
- Figure 84. Latin America Epigenomics Market Analysis, By Technology, 2020, 2024 and 2034
- Figure 85. Latin America Epigenomics Market Attractiveness Analysis, By Technology
- Figure 86. Latin America Epigenomics Market (US$ Mn), by DNA Methylation, 2020-2034
- Figure 87. Latin America Epigenomics Market (US$ Mn), by MicroRNA Modification, 2020-2034
- Figure 88. Latin America Epigenomics Market (US$ Mn), by Large Non-Coding RNA, 2020-2034
- Figure 89. Latin America Epigenomics Market (US$ Mn), by Histone Methylation, 2020-2034
- Figure 90. Latin America Epigenomics Market (US$ Mn), by Histone Acetylation, 2020-2034
- Figure 91. Latin America Epigenomics Market Analysis, By Country, 2020, 2024 and 2034
- Figure 92. Latin America Epigenomics Market Attractiveness Analysis, By Country
- Figure 93. Middle East & Africa Epigenomics Market Analysis, By Product, 2020, 2024 and 2034
- Figure 94. Middle East & Africa Epigenomics Market Attractiveness Analysis, By Product
- Figure 95. Middle East & Africa Epigenomics Market (US$ Mn), by Reagents, 2020-2034
- Figure 96. Middle East & Africa Epigenomics Market (US$ Mn), by Kits, 2020-2034
- Figure 97. Middle East & Africa Epigenomics Market (US$ Mn), by Enzymes, 2020-2034
- Figure 98. Middle East & Africa Epigenomics Market (US$ Mn), by Instruments, 2020-2034
- Figure 99. Middle East & Africa Epigenomics Market (US$ Mn), by Services, 2020-2034
- Figure 100. Middle East & Africa Epigenomics Market Analysis, By Application, 2020, 2024 and 2034
- Figure 101. Middle East & Africa Epigenomics Market Attractiveness Analysis, By Application
- Figure 102. Middle East & Africa Epigenomics Market (US$ Mn), by Oncology, 2020-2034
- Figure 103. Middle East & Africa Epigenomics Market (US$ Mn), by Non-Oncology, 2020-2034
- Figure 104. Middle East & Africa Epigenomics Market Analysis, By Technology, 2020, 2024 and 2034
- Figure 105. Middle East & Africa Epigenomics Market Attractiveness Analysis, By Technology
- Figure 106. Middle East & Africa Epigenomics Market (US$ Mn), by DNA Methylation, 2020-2034
- Figure 107. Middle East & Africa Epigenomics Market (US$ Mn), by MicroRNA Modification, 2020-2034
- Figure 108. Middle East & Africa Epigenomics Market (US$ Mn), by Large Non-Coding RNA, 2020-2034
- Figure 109. Middle East & Africa Epigenomics Market (US$ Mn), by Histone Methylation, 2020-2034
- Figure 110. Middle East & Africa Epigenomics Market (US$ Mn), by Histone Acetylation, 2020-2034
- Figure 111. Middle East & Africa Epigenomics Market Analysis, By Country, 2020, 2024 and 2034
- Figure 112. Middle East & Africa Epigenomics Market Attractiveness Analysis, By Country
- 1. Executive Summary
-
- Zymo Research
- Thermo Fisher Scientific Company Profile
- QIAGEN NV Company Profile
- PerkinElmer
- Pacific Biosciences
- New England Biolabs
- Merck KGaA Company Profile
- Illumina
- Bio-Rad Laboratories, Inc. Company Profile
- Agilent Technologies Inc. Company Profile
- Active Motif
- Abcam
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible